These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26501470)

  • 1. The Health Burden of Invasive Meningococcal Disease: A Systematic Review.
    Strifler L; Morris SK; Dang V; Tu HA; Minhas RS; Jamieson FB; Deeks SL; Crowcroft NS; Sander B
    J Pediatric Infect Dis Soc; 2016 Dec; 5(4):417-430. PubMed ID: 26501470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers.
    Olbrich KJ; Müller D; Schumacher S; Beck E; Meszaros K; Koerber F
    Infect Dis Ther; 2018 Dec; 7(4):421-438. PubMed ID: 30267220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequelae at Hospital Discharge in 61 Children With Invasive Meningococcal Disease, Chile, 2009-2019.
    Arteta-Acosta C; Villena Martínez R; Santolaya de Pablo ME
    Pediatr Infect Dis J; 2022 Aug; 41(8):607-613. PubMed ID: 35421054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of sequelae after invasive meningococcal disease.
    Voss SS; Nielsen J; Valentiner-Branth P
    BMC Infect Dis; 2022 Feb; 22(1):148. PubMed ID: 35148717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children.
    Wang B; Haji Ali Afzali H; Marshall H
    Vaccine; 2014 Aug; 32(37):4791-8. PubMed ID: 24998605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.
    Viner RM; Booy R; Johnson H; Edmunds WJ; Hudson L; Bedford H; Kaczmarski E; Rajput K; Ramsay M; Christie D
    Lancet Neurol; 2012 Sep; 11(9):774-83. PubMed ID: 22863608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis.
    Guedes S; Bricout H; Langevin E; Tong S; Bertrand-Gerentes I
    BMC Public Health; 2022 Mar; 22(1):521. PubMed ID: 35296287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.
    Marten O; Koerber F; Bloom D; Bullinger M; Buysse C; Christensen H; De Wals P; Dohna-Schwake C; Henneke P; Kirchner M; Knuf M; Lawrenz B; Monteiro AL; Sevilla JP; Van de Velde N; Welte R; Wright C; Greiner W
    Health Qual Life Outcomes; 2019 May; 17(1):87. PubMed ID: 31118091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.
    Marshall H; McMillan M; Wang B; Booy R; Afzali H; Buttery J; Blyth CC; Richmond P; Shaw D; Gordon D; Barton B
    BMJ Open; 2019 Dec; 9(12):e032583. PubMed ID: 31888931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.
    Huang L; Heuer OD; Janßen S; Häckl D; Schmedt N
    PLoS One; 2020; 15(1):e0228020. PubMed ID: 31990941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review.
    Shen J; Begum N; Ruiz-Garcia Y; Martinon-Torres F; Bekkat-Berkani R; Meszaros K
    BMC Public Health; 2022 May; 22(1):1078. PubMed ID: 35641955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study.
    Kennedy ITR; van Hoek AJ; Ribeiro S; Christensen H; Edmunds WJ; Ramsay ME; Ladhani SN
    PLoS One; 2017; 12(5):e0177082. PubMed ID: 28545152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
    Parent du Chatelet I; Deghmane AE; Antona D; Hong E; Fonteneau L; Taha MK; Lévy-Bruhl D
    J Infect; 2017 Jun; 74(6):564-574. PubMed ID: 28279715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco smoking and meningococcal disease in adolescents and young adults: a systematic review and meta-analysis.
    Pilat EK; Stuart JM; French CE
    J Infect; 2021 May; 82(5):135-144. PubMed ID: 33610686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
    Weil-Olivier C; Taha MK; Bouée S; Emery C; Loncle-Provot V; Nachbaur G; Beck E; Pribil C
    Hum Vaccin Immunother; 2022 Dec; 18(1):2021764. PubMed ID: 35192785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Sequelae of Invasive Meningococcal Disease in the United States.
    Marshall GS; McCormick ZL; Johns JS; Verduzco-Gutierrez M; Herrera-Restrepo O; Harrison LH
    Infect Dis Ther; 2024 Nov; 13(11):2213-2220. PubMed ID: 39269567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM).
    Shen J; Bouée S; Aris E; Emery C; Beck EC
    Infect Dis Ther; 2022 Feb; 11(1):249-262. PubMed ID: 34791633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.